SCHEMBL25857027

SCHEMBL25857027

CNC(=O)/N=C(\N)Nc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.50
GRIN2D O15399 1/20 0.50
GRIN3B O60391 1/20 0.50
LMNA P02545 1/20 0.50
CYP2D6 P10635 1/20 0.50
SLC6A2 P23975 1/20 0.50
KMT2A Q03164 1/20 0.50
GRIN1 Q05586 1/20 0.50
GRIN2A Q12879 1/20 0.50
GRIN2B Q13224 1/20 0.50
GRIN2C Q14957 1/20 0.50
GRIN3A Q8TCU5 1/20 0.50
SIGMAR1 Q99720 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
HSD17B10 Q99714 2/20 0.47
NAPRT Q6XQN6 1/20 0.47
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.46
GFER P55789 1/20 0.46
TP53 P04637 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24746975 0.87 GRIN2D (0.55) KDM1AGRIN2DGRIN3BLMNACYP2D6
SCHEMBL24747095 0.84 GRIN2D (0.52) KDM1AGRIN2DGRIN3BLMNACYP2D6
SCHEMBL10592440 0.76 KMT2A (0.52) KDM1AGRIN2DGRIN3BLMNACYP2D6
SCHEMBL25882558 0.76 KDM1A (0.47) KDM1AGRIN2DGRIN3BLMNACYP2D6
SCHEMBL24747001 0.75 KDM1A (0.46) KDM1AGRIN2DGRIN3BLMNACYP2D6
SCHEMBL25857038 0.74 NPC1 (0.60) LMNAKMT2AGAATSHRSMN1; SMN2
SCHEMBL4475840 0.73 MAPT (0.51) KDM1AGRIN2DGRIN3BLMNACYP2D6
Phenyl Biguanide SCHEMBL4100255 0.73 KMT2A (0.57) KDM1AGRIN2DGRIN3BLMNACYP2D6
Phenyl Biguanide SCHEMBL13919685 0.73 KMT2A (0.57) KDM1AGRIN2DGRIN3BLMNACYP2D6
Phenyl Biguanide SCHEMBL4100253 0.73 KMT2A (0.57) KDM1AGRIN2DGRIN3BLMNACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11801228-B2 Modified guanidine-containing polymers for biologic delivery THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) 2023-10-31 US disclosed
US-20230225982-A1 MODIFIED GUANIDINE-CONTAINING POLYMERS FOR BIOLOGIC DELIVERY THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230225982-A1 MODIFIED GUANIDINE-CONTAINING POLYMERS FOR BIOLOGIC DELIVERY GMPS, RNMT, GUCY1A1 KDM1A 1558/4885GRIN2D 4742/4885GRIN3B 3977/4885
US-11801228-B2 Modified guanidine-containing polymers for biologic delivery GMPS, RNMT, GUCY1A1 KDM1A 1558/4885GRIN2D 4742/4885GRIN3B 3977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.